JAG
MEDP icon

Journey Advisory Group’s Medpace MEDP Stock Holding History

Journey Advisory Group’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$566K Buy
1,068
+283
+36% +$131K 0.04% 195
2026
Q1 		$377K Buy
785
+12
+2% +$6.14K 0.03% 201
2025
Q4 		$434K Sell
773
-82
-10% -$46.5K 0.04% 200
2025
Q3 		$440K Sell
855
-25
-3% -$10.9K 0.03% 203
2025
Q2 		$276K Sell
880
-1,747
-67% -$524K 0.02% 250
2025
Q1 		$800K Buy
2,627
+237
+10% +$79.7K 0.07% 165
2024
Q4 		$984K Hold
2,390
– – 0.12% 114
2024
Q3 		$984K Hold
2,390
– – 0.12% 114
2024
Q2 		$984K Buy
2,390
+44
+2% +$17.4K 0.12% 114
2024
Q1 		$948K Buy
2,346
+444
+23% +$156K 0.12% 120
2023
Q4 		$583K Buy
1,902
+82
+5% +$22.1K 0.08% 139
2023
Q3 		$441K Hold
1,820
– – 0.07% 156
2023
Q2 		$437K Hold
1,820
– – 0.07% 159
2023
Q1 		$342K Sell
1,820
-70
-4% -$14.5K 0.05% 173
2022
Q4 		$401K Buy
1,890
+265
+16% +$52.9K 0.1% 151
2022
Q3 		$255K Buy
1,625
+50
+3% +$7.98K 0.07% 202
2022
Q2 		$264K Buy
+1,575
New +$228K 0.06% 214
2022
Q1 		– Sell
-975
Closed -$212K – 220
2021
Q4 		$212K Buy
+975
New +$204K 0.06% 202

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Journey Advisory Group's MEDP Position: Q2 2026 in Review

Journey Advisory Group increased its Medpace (MEDP) stake by 36% in Q2 2026, buying an estimated $131K and bringing the position to 1,068 shares worth $566K. The position accounts for 0.04% of the portfolio, ranked #195.

Journey Advisory Group first reported a position in MEDP in Q4 2021 and has held it in 18 quarters since. The position peaked at $984K in Q4 2024. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Journey Advisory Group held 1,068 shares of Medpace worth $566K as of Q2 2026.
  • Journey Advisory Group bought 283 Medpace shares in Q2 2026, an estimated $131K.
  • Medpace made up 0.04% of Journey Advisory Group's portfolio in Q2 2026, its #195 holding.
  • Journey Advisory Group first reported a position in Medpace in Q4 2021 and has held it in 18 quarters since.
  • Journey Advisory Group's Medpace position peaked at $984K in Q4 2024.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Journey Advisory Group's 13F filing for Q2 2026, filed 4 Aug 2026.